AstraZeneca PLC CHANGE TO ASTRAZENECA BOARD OF DIRECTORS (9770K)
September 28 2016 - 2:01AM
UK Regulatory
TIDMAZN
RNS Number : 9770K
AstraZeneca PLC
28 September 2016
28 September 2016 07:00
CHANGE TO ASTRAZENECA BOARD OF DIRECTORS
AstraZeneca today announced that Dr Cornelia (Cori) Bargmann, a
Non-Executive Director, will step down from the Board of
AstraZeneca PLC and as a member of the Company's Science Committee
with effect from 1 October 2016. Dr Bargmann recently accepted a
new position as President of Chan Zuckerberg Science, part of the
Chan Zuckerberg Initiative.
Leif Johansson, AstraZeneca Chairman, said: "We congratulate
Cori on her new appointment and thank her for her contribution to
AstraZeneca in the last 18 months. We are sorry to see her leave
the AstraZeneca Board but fully understand her decision to step
down to focus on her new assignment."
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company
that focuses on the discovery, development and commercialisation of
prescription medicines, primarily for the treatment of diseases in
three therapy areas - Respiratory and Autoimmunity, Cardiovascular
and Metabolic Diseases, and Oncology. The Company is also active in
inflammation, infection and neuroscience through numerous
collaborations. AstraZeneca operates in over 100 countries and its
innovative medicines are used by millions of patients worldwide.
For more information please visit: www.astrazeneca.com
CONTACTS
Media Enquiries
Neil Burrows UK/Global +44 203 749 5637
Vanessa Rhodes UK/Global +44 203 749 5736
Karen Birmingham UK/Global +44 203 749 5634
Rob Skelding UK/Global +44 203 749 5821
+46 8 553 260
Jacob Lund Sweden 20
Michele Meixell US +1 302 885 2677
Investor Relations
UK
Thomas Kudsk
Larsen +44 203 749 5712
Finance, Fixed +44 7881 615
Craig Marks Income, M&A 764
Respiratory &
Nick Stone Autoimmunity +44 203 749 5716
Henry Wheeler Oncology +44 203 749 5797
Christer Gruvris Infection & Neuroscience +44 203 749 5711
US
Cardiovascular
Lindsey Trickett & Metabolic Diseases +1 240 543 7970
Mitchell Chan Oncology +1 240 477 3771
Toll-free +1 866 381 7277
Adrian Kemp
Company Secretary
AstraZeneca PLC
-ENDS-
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAXDLFLQKFFBBB
(END) Dow Jones Newswires
September 28, 2016 02:01 ET (06:01 GMT)
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024